COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,362 Articles (22,803 medRxiv, 8,559 bioRxiv)

Most recent first Previous |  Page 204: Articles 2031-2040  | Next

From HHV-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID.
Maes, M., Almulla, A. F., Tang, X., Stoyanova, K., Vojdani, A.
10.1101/2024.06.28.24309682 — Posted: 2024-06-30
Risk reduction in SARS-CoV-2 infection and reinfection conferred by humoral antibody levels among essential workers during Omicron predominance
Hollister, J., Porter, C., Sprissler, R., Beitel, S. C., Romine, J. K., Uhrlaub, J. L., Grant, L., Yoo, Y. M., Fowlkes, A., Britton, A., Olsho, L. E. W., Newes-Adeyi, G., Fuller, S., Zheng, P. Q., Gaglani, M. G., Rose, S., Dunnigan, K., Naleway, A. L., Gwynn, L., Caban-Martinez, A., Schaefer Solle, N., Tyner, H. L., Philips, A. L., Hegmann, K. T., Yoon, S., Lutrick, K., Burgess, J. L., Ellingson, K. D.
10.1101/2024.06.28.24309655 — Posted: 2024-06-30
Inpatient Burden of COVID-19 in Japan: A Retrospective Cohort Study
Andersen, K. M., Brouillette, M. A., Togo, K., Tanabe, K., Carter, B. T., Kent, M. T., Ding, Y., Curcio, D., Welch, V., McGrath, L. J., Ilyas, B., Ito, S.
10.1101/2024.06.28.24309640 — Posted: 2024-06-30
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study
Vivaldi, G., Talaei, M., Pfeffer, P. E., Shaheen, S. O., Martineau, A. R.
10.1101/2024.06.28.24309666 — Posted: 2024-06-30
The COVID-19 pandemic in Canadas provinces: mitigation measures and outcomes
Grootendorst, P.
10.1101/2024.06.28.24309653 — Posted: 2024-06-30
Gut microbial profiling of COVID-19 patients in Uganda
Kateete, D. P., Lubega, C., Galiwango, R., Nasinghe, E., Mbabazi, M., Jjingo, D., Elliott, A.
10.1101/2024.06.28.601197 — Posted: 2024-06-30
AntiCPs-CompML: A Comprehensive Fast Track ML method to predict Anti-Corona Peptides
Bist, P. S., Bhattarai, S., Tayara, H., Chong, K. T.
10.1101/2024.06.27.601090 — Posted: 2024-06-29
Covid-19 vaccination decisions and impacts of vaccine mandates: A cross sectional survey of healthcare workers in Ontario, Canada
Chaufan, C., Hemsing, N., Moncrieffe, R.
10.1101/2024.06.23.24309372 — Posted: 2024-06-28
Admission systolic blood pressure and obesity correlate with fatal and severe acute COVID-19 in the population of New Orleans, LA.
Drouin, A., Liu, S., Theberge, M., Pulapaka, A. V., Zha, Y., Rittmeyer, W., Maylin, M., Rothwell, W. B., Adhikari, P., Raynaud, P., Ferdinand, K., Fusco, D.
10.1101/2024.06.27.24309604 — Posted: 2024-06-28
Epidemiological and phylogenetic analyses of public SARS-CoV-2 data from Malawi
Afuleni, M. K., Cahuantzi, R., Lythgoe, K. A., Mulaga, A. N., Hall, I., Johnson, O., House, T.
10.1101/2024.06.28.24309607 — Posted: 2024-06-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).